An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation.

[1]  B. Sandmaier,et al.  An antibody to CD44 enhances hematopoiesis in long-term marrow cultures. , 1996, Experimental hematology.

[2]  B. Sandmaier,et al.  Mechanisms of enhancement of natural killer activity by an antibody to CD44: increase in conjugate formation and release of tumor necrosis factor alpha. , 1995, Cellular immunology.

[3]  H. Deeg,et al.  DLA-identical marrow grafts after low-dose total-body irradiation. Addition of viable donor peripheral blood mononuclear cells does not enhance engraftment. , 1995, Transplantation.

[4]  H. Deeg,et al.  DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors. , 1994, Blood.

[5]  E. Bryant,et al.  USE OF (CA)n POLYMORPHISMS TO DETERMINE THE ORIGIN OF BLOOD CELLS AFTER ALLOGENEIC CANINE MARROW GRAFTING , 1994, Transplantation.

[6]  B. Sandmaier,et al.  'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex. , 1994, Experimental hematology.

[7]  R. Storb,et al.  A simple restriction fragment-length polymorphism assay for MHC class II gene testing of dog families. , 1994, Transplantation.

[8]  H. Deeg,et al.  Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model. , 1993, International journal of radiation oncology, biology, physics.

[9]  B. Sandmaier,et al.  Enhancement of natural killer activity by an antibody to CD44. , 1993, Journal of immunology.

[10]  R. Storb,et al.  An antibody that facilitates hematopoietic engraftment recognizes CD44. , 1990, Blood.

[11]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.

[12]  M. Pepe,et al.  Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts. , 1989, Blood.

[13]  H. Deeg,et al.  FAILURE OF ANTITHYMOCYTE SERUM POSTGRAFTING TO OVERCOME “RESISTANCE” TO DLANONIDENTICAL CANINE MARROW GRAFTS1 , 1988, Transplantation.

[14]  H. Deeg,et al.  FACILITATION OF ENGRAFTMENT OF DLA‐NONIDENTICAL MARROW BY TREATMENT OF RECIPIENTS WITH MONOCLONAL ANTIBODY DIRECTED AGAINST MARROW CELLS SURVIVING RADIATION , 1987, Transplantation.

[15]  H. Deeg,et al.  JOINT REPORT OF THE THIRD INTERNATIONAL WORKSHOP ON CANINE IMMUNOGENETICS: II. ANALYSIS OF THE SEROLOGICAL TYPING OF CELLS , 1987, Transplantation.

[16]  H. Deeg,et al.  FAILURE OF ALLOGENEIC CANINE MARROW GRAFTS AFTER TOTAL‐BODY IRRADIATION: ALLOGENEIC “RESISTANCE” VERSUS TRANSFUSION‐INDUCED SENSITIZATION , 1986, Transplantation.

[17]  H. Deeg,et al.  Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors. , 1986, Blood.

[18]  H. Deeg,et al.  Joint report of the Third International Workshop on Canine Immunogenetics. I. Analysis of homozygous typing cells. , 1986, Transplantation.

[19]  H. Deeg,et al.  CYCLOSPORIN A AND METHOTREXATE IN CANINE MARROW TRANSPLANTATION: ENGRAFTMENT, GRAFT‐VERSUS-HOST DISEASE, AND INDUCTION OF TOLERANCE , 1982, Transplantation.

[20]  H. Deeg,et al.  Cyclosporin-A: effect on marrow engraftment and graft-versus-host disease in dogs. , 1981, Transplantation proceedings.

[21]  R. Storb,et al.  HEMOPOIETIC GRAFTS BETWEEN DLA‐IDENTICAL CANINE LITTERMATES FOLLOWING DIMETHYL MYLERAN: EVIDENCE FOR RESISTANCE TO GRAFTS NOT ASSOCIATED WITH DLA AND ABROGATED BY ANTITHYMOCYTE SERUM , 1977, Transplantation.